TD Cowen upgraded shares of Azenta (NASDAQ:AZTA – Free Report) to a hold rating in a report issued on Thursday morning,Zacks.com reports.
Other equities analysts also recently issued research reports about the stock. Stephens reiterated an “overweight” rating and issued a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd. Needham & Company LLC raised their target price on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th. Finally, Evercore ISI raised their target price on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $58.75.
Check Out Our Latest Stock Analysis on Azenta
Azenta Stock Up 1.6 %
Azenta (NASDAQ:AZTA – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, research analysts anticipate that Azenta will post 0.53 EPS for the current year.
Institutional Investors Weigh In On Azenta
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Farther Finance Advisors LLC grew its holdings in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after buying an additional 256 shares in the last quarter. QRG Capital Management Inc. grew its holdings in shares of Azenta by 6.6% during the third quarter. QRG Capital Management Inc. now owns 6,156 shares of the company’s stock worth $298,000 after buying an additional 383 shares in the last quarter. Ballentine Partners LLC grew its holdings in shares of Azenta by 2.0% during the fourth quarter. Ballentine Partners LLC now owns 20,340 shares of the company’s stock worth $1,017,000 after buying an additional 404 shares in the last quarter. Boothbay Fund Management LLC grew its holdings in shares of Azenta by 8.4% during the fourth quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company’s stock worth $329,000 after buying an additional 509 shares in the last quarter. Finally, Picton Mahoney Asset Management grew its holdings in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company’s stock worth $35,000 after buying an additional 532 shares in the last quarter. 99.08% of the stock is currently owned by hedge funds and other institutional investors.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- How to Short a Stock in 5 Easy Steps
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Investing in the High PE Growth Stocks
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.